The goal of the BIO Investor Forum is to bring together early and established private companies, as well as emerging public companies, with top private and public equity investors. Presentations are a key programming element, and allow companies to discuss their pipeline, R&D activities, and future goals to this exclusive audience, fostering the development of important new medicines that will expand the industry’s pipeline.
Companies interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics, or platform technologies. Service providers will not be considered. For questions about company presentations, please read our FAQ here.
Now accepting applications for the 2018 BIO Investor Forum.
Please contact firstname.lastname@example.org for more information.